Pyros Pharmaceuticals

Join us for dinner at our symposium on infantile spasms this evening, at the Child Neurology Society (CNS) Annual Meeting at 5 PM PST, Ballroom A. #CNSAM

Come join us at the Child Neurology Society Annual Meeting at the Marriott Marquis San Diego! Visit our inaugural booth # 407 in the Pacific Ballroom on 11/11 and 11/12, our team will be onsite and eager to connect. Also, please join us on 11/12 at 5PM PT in Ballroom A at our Symposium focused on Infantile Spasms with a group of leading experts in this space. Dinner will be served. Looking forward to seeing you there! #ChildNeurology #InfantileSpasms #CNS2024

Epilepsy Awareness Day is almost here! We look forward to supporting families of babies with infantile spasms and HCPs. We’ll be speaking as well. Register to be part of this special yearly gathering at https://hubs.li/Q02WwVrG0

Pyros Pharmaceuticals will be at the 2024 Child Neurology Society (CNS) Annual Meeting. Join us to learn about new VIGAFYDE? (vigabatrin) Oral Solution. Visit https://hubs.li/Q02Wb_cq0 to see our events. #CNSAM

Today is Child Neurology Awareness Day! Neurological conditions affect many children every year, and among them, infantile spasms is one of the most urgent and challenging. These rare seizures typically begin in the first year of life, often leading to developmental delays. On this day, we honor the resilience of these young patients and the dedication of caregivers, healthcare professionals, and researchers working to improve their lives. Raising awareness is critical. By understanding the impact of infantile spasms and advocating for better resources, we can create a brighter future for these children and their families. Learn more about infantile spasms and explore resources for caregivers visit KnowInfantileSpasms: https://lnkd.in/digum_mv Let’s continue to share knowledge, stories, and a commitment to support children with neurological conditions. #ChildNeurologyAwarenessDay #InfantileSpasms #PediatricNeurology #CaregiverSupport #Advocacy #Community #ChildNeuologyFoundation #SEEN

We’re thrilled to announce that Pyros Pharmaceuticals has been acquired by Bora Pharmaceuticals expanding Bora's footprint in rare disease treatments. This strategic move combines Pyros' innovative therapies with Bora's global capabilities, positioning us to make a greater impact for patients with infantile spasms and beyond. https://lnkd.in/eMy9k3ze #RareDisease #PharmaAcquisition #InfantileSpasms #HealthcareInnovation

Register today for a virtual presentation to learn about new VIGAFYDE? (vigabatrin) for infantile spasms. 3 dates to choose from. pathlms.com/pyros

Introducing VIGAFYDE? (vigabatrin)! The first and only, ready-to-use formulation is NOW AVAILABLE. Prescribe consistent concentration with every dose. https://hubs.li/Q02Pn74W0 Accurate formulation of vigabatrin with VIGAFYDE: https://hubs.li/Q02Pn6Bd0

VIGAFYDE is the FIRST and ONLY, ready-to-use, liquid formulation of vigabatrin: Premixed for peace of mind with every dose. Please see full PI, incl. BOXED WARNING: https://hubs.li/Q02NSfV60 Liquid vigabatrin is now available: https://hubs.li/Q02NS8zh0

Exciting news from Pyros Pharmaceuticals! We're thrilled to announce the official launch of VIGAFYDE? (vigabatrin) Oral Solution, the first and only liquid vigabatrin. VIGAFYDE? represents an important advancement for patients. This launch underscores our commitment to improving the lives of patients and their families by delivering innovative therapies that address unmet medical needs. Please see full PI, including BOXED WARNING https://bit.ly/4cRpIPu. #PharmaInnovation #PatientCare #VIGAFYDELaunch